abstract Newer therapies are needed for patients with primary biliary cirrhosis and incomplete response to ursodeoxycholic acid (UDCA). Fenofibrate is a fibric acid postulated to regulate immune response and cell proliferation.
authors Levy, C Soldevila Pico, Consuelo Lindor, K. Peter, Joy Firpi-Morell, Roberto Nelson, David R Keach, J. Morelli, Giuseppe Petz, J. Cabrera, Roniel Clark, Ginger
has subject area Adult Aged Cholagogues and Choleretics Drug Therapy, Combination Female Fenofibrate Humans Hypolipidemic Agents Liver Cirrhosis, Biliary Male Middle Aged Pilot Projects Statistics as Topic Treatment Outcome Ursodeoxycholic Acid